Stockscreener 앱 받기
6.26
6.28%
0.37
전일 마감가:
$5.89
열려 있는:
$5.83
하루 거래량:
10,658
Relative Volume:
0.17
시가총액:
$59.23M
수익:
$75.67M
순이익/손실:
$-31.15M
주가수익비율:
-22.54
EPS:
-0.2777
순현금흐름:
$-39.79M
1주 성능:
+4.33%
1개월 성능:
-3.69%
6개월 성능:
-57.64%
1년 성능:
-65.79%
1일 변동 폭
$5.55
$6.33
1주일 범위
$5.55
$6.3525
52주 변동 폭
$4.815
$31.50
Optinose Inc Stock (OPTN) Company Profile
명칭
Optinose Inc
전화
267-364-3500
주소
777 TOWNSHIP LINE ROAD, YARDLEY, PA
OPTN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
6.045 | 59.23M | 75.67M | -31.15M | -39.79M | -0.2777 |
|
ZTS
Zoetis Inc
|
175.98 | 77.71B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.67 | 43.05B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.40 | 42.23B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.32 | 19.33B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
151.44 | 15.26B | 2.24B | 385.90M | 440.10M | 3.73 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-03 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-21 | 개시 | Lake Street | Buy |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2019-12-18 | 개시 | Cowen | Outperform |
| 2018-08-08 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Optinose Inc 주식(OPTN)의 최신 뉴스
OptiNose, Inc. (NASDAQ:OPTN) Sees Significant Decline in Short Interest - MarketBeat
Optinose Reports $22.4 Million in Preliminary Q4 Revenue for XHANCE - MSN
OptiNose (STU:0OP0) Inventories, Raw Materials & Components : €2.05 Mil (As of Sep. 2024) - GuruFocus.com
OptiNose (FRA:0OP0) Earnings per Share (Diluted) : €-3.84 (TTM As of Sep. 2024) - GuruFocus.com
Lake Street Capital Issues Pessimistic Forecast for OptiNose (NASDAQ:OPTN) Stock Price - Defense World
OptiNose (NASDAQ:OPTN) Price Target Cut to $17.00 by Analysts at Lake Street Capital - MarketBeat
OptiNose (FRA:0OP0) Short-Term Capital Lease Obligation : €0.91 Mil (As of Sep. 2024) - GuruFocus.com
Optinose price target adjusted for stock split at Lake Street - Yahoo Finance
Optinose reports preliminary Q4 2024 XHANCE revenue - MSN
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million - GlobeNewswire
OPTNOptiNose, Inc. Latest Stock News & Market Updates - StockTitan
Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL
Optinose Reports Strong Q4: XHANCE Revenue Hits $22.4M with 20% Prescription Growth - StockTitan
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - GlobeNewswire Inc.
OptiNose (STU:0OP0) Profitability Rank : 3 (As of Sep. 2024) - GuruFocus.com
OptiNose (STU:0OP0) Change In Inventory : €-3.06 Mil (TTM As of Sep. 2024) - GuruFocus.com
OptiNose, Inc. (NASDAQ:OPTN) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
OptiNose (FRA:0OP0) Cyclically Adjusted Price-to-FCF : (As of Jan. 06, 2025) - GuruFocus.com
HC Wainwright Comments on OptiNose FY2029 Earnings - MarketBeat
HC Wainwright Forecasts OptiNose FY2029 Earnings - Defense World
Optinose price target adjusted for stock split at H.C. Wainwright - MSN
HC Wainwright Issues Positive Forecast for OptiNose (NASDAQ:OPTN) Stock Price - Defense World
Optinose stock price target raised at H.C. Wainwright given reverse split - Investing.com Canada
OptiNose (NASDAQ:OPTN) Shares Down 6.1%Time to Sell? - MarketBeat
OptiNose: Q1 Earnings Snapshot - Marketscreener.com
OptiNose, Inc. Announces Executive Appointments - Marketscreener.com
Optinose Announces Board Changes - Marketscreener.com
OptiNose stock hits 52-week high of $6.2 amid market fluctuations - Investing.com Nigeria
OptiNose stock hits 52-week high of $6.2 amid market fluctuations By Investing.com - Investing.com South Africa
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
OptiNose (NASDAQ:OPTN) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn
Optinose Announces 1-for-15 Reverse Stock Split - MSN
Optinose to effect 1-for-15 reverse stock split for Nasdaq compliance - MSN
OptiNose, Inc. (NASDAQ:OPTN) Sees Large Decline in Short Interest - MarketBeat
Yardley-Based Optinose Implements Reverse Stock Split to Boost Share Price, Avoid NASDAQ Delisting - BUCKSCO.Today
OptiNose Stock Scheduled to Reverse Split on Tuesday, December 31st (NASDAQ:OPTN) - Defense World
Optinose to enact 1-for-15 reverse stock split under threat of Nasdaq delisting - The Business Journals
Optinose announces reverse stock split to meet Nasdaq rules - Investing.com
Optinose (OPTN) Announces 1-for-15 Reverse Stock Split to Maintain Nasdaq Listing Compliance - StockTitan
Optinose CEO Mahmoud Ramy A sells $2,030 in common stock By Investing.com - Investing.com South Africa
Optinose CEO Mahmoud Ramy A sells $2,030 in common stock - Investing.com India
Optinose chief legal officer sells shares worth $1,342 By Investing.com - Investing.com Australia
Optinose chief legal officer sells shares worth $1,342 - Investing.com
Optinose Inc (OPTN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.89%
0.73%
자본화:
|
볼륨(24시간):